This is the broadest documented form of Hadacol’s marketed promise: a list of named, often life-threatening diseases that the tonic’s advertising and published testimonials claimed to relieve or cure (Gisclair 2018). The Federal Trade Commission specifically objected to the cancer and diabetes claims within this list (Gisclair 2018), and by October 1951 Time reported the FTC had challenged Hadacol’s marketing claims generally as “false, misleading and deceptive” (Time 1951). No clinical study of Hadacol supporting any disease-specific claim on this list appears in any source in this bundle; the claim is logged as testimonial-grade and refuted on that direct, contemporaneous regulatory and press record.